Yale New Haven (Conn.) Children's Hospital has selected Lakshmanan Krishnamurti, MD, as chief of pediatric hematology and oncology, effective Oct. 1.
In his new role, Dr. Krishnamurti will lead all areas of pediatric hematology, oncology and bone marrow transplant/cellular therapy programs, with a focus on enhancing clinical programs and advancing research efforts.
He is known for his expertise in bone marrow transplant and for treatment of hemoglobinopathies — a group of inherited blood disorders and diseases that mainly affect red blood cells. Dr. Krishnamurti has studied sickle cell disease for more than 22 years, and is currently working to identify opportunities for the use of bone marrow transplantation as a curative therapy for genetic diseases, according to a June 28 news release.
Most recently, he served as a pediatrics professor and directed the bone marrow transplant program at Atlanta-based Emory University.
He earned his medical degree from the University of Poona, Armed Forces Medical College in India.
Dr. Krishnamurti succeeds Farzana Pashankar, MD, who has served as the interim chief of pediatric hematology and oncology for the last year.